Investigation of a pulsed electrothermal thruster system

The performance of an ablative wall Pulsed Electrothermal (PET) thruster is accurately characterized on a calibrated thrust stand, using polyethylene propellant. The thruster is tested for four configurations of capillary length and pulse length. The exhaust velocity is determined with twin time-of-flight photodiode stagnation probes, and the ablated mass is measured from the loss over ten shots. Based on the measured thrust impulse and the ablated mass, the specific impulse varies from 1000 to 1750 seconds. The thrust to power varies from .05 N/kW (quasi-steady mode) to .10 N/kW (unsteady mode). The thruster efficiency varies from .56 at 1000 seconds to .42 at 1750 seconds. A conceptual design is presented for a 40 kW PET propulsion system. The point design system performance is .62 system efficiency at 1000 seconds specific impulse. The system's reliability is enhanced by incorporating 20, 20 kW thruster modules which are fired in pairs. The thruster design is non-ablative, and uses water propellant, from a central storage tank, injected through the cathode

Very High Mach Number Electrostatic Shocks in Collisionless Plasmas

The kinetic theory of collisionless electrostatic shocks resulting from the collision of plasma slabs with different temperatures and densities is presented. The theoretical results are confirmed by self-consistent particle-in-cell simulations, revealing the formation and stable propagation of electrostatic shocks with very high Mach numbers ($M \gg 10$), well above the predictions of the classical theories for electrostatic shocks.Comment: 6 pages, submitted to Phys. Rev. Let

Investigation of a repetitive pulsed electrothermal thruster

A pulsed electrothermal (PET) thruster with 1000:1 ratio nozzle is tested in a repetitive mode on water propellant. The thruster is driven by a 60J pulse forming network at repetition rates up to 10 Hz (600W). The pulse forming network has a .31 ohm impedance, well matched to the capillary discharge resistance of .40 ohm, and is directly coupled to the thruster electrodes without a switch. The discharge is initiated by high voltage breakdown, typically at 2500V, through the water vapor in the interelectrode gap. Water is injected as a jet through a .37 mm orifice on the thruster axis. Thruster voltage, current and impulse bit are recorded for several seconds at various power supply currents. Thruster to power ratio is typically T/P = .07 N/kW. Tank background pressure precludes direct measurement of exhaust velocity which is inferred from calculated pressure and temperature in the discharge to be about 14 km/sec. Efficiency, based on this velocity and measured T/P is .54 + or - .07. Thruster ablation is zero at the throat and becomes measurable further upstream, indicating that radiative ablation is occurring late in the pulse

Multiwavelength Study on Solar and Interplanetary Origins of the Strongest Geomagnetic Storm of Solar Cycle 23

We study the solar sources of an intense geomagnetic storm of solar cycle 23 that occurred on 20 November 2003, based on ground- and space-based multiwavelength observations. The coronal mass ejections (CMEs) responsible for the above geomagnetic storm originated from the super-active region NOAA 10501. We investigate the H-alpha observations of the flare events made with a 15 cm solar tower telescope at ARIES, Nainital, India. The propagation characteristics of the CMEs have been derived from the three-dimensional images of the solar wind (i.e., density and speed) obtained from the interplanetary scintillation data, supplemented with other ground- and space-based measurements. The TRACE, SXI and H-alpha observations revealed two successive ejections (of speeds ~350 and ~100 km/s), originating from the same filament channel, which were associated with two high speed CMEs (~1223 and ~1660 km/s, respectively). These two ejections generated propagating fast shock waves (i.e., fast drifting type II radio bursts) in the corona. The interaction of these CMEs along the Sun-Earth line has led to the severity of the storm. According to our investigation, the interplanetary medium consisted of two merging magnetic clouds (MCs) that preserved their identity during their propagation. These magnetic clouds made the interplanetary magnetic field (IMF) southward for a long time, which reconnected with the geomagnetic field, resulting the super-storm (Dst_peak=-472 nT) on the Earth.Comment: 24 pages, 16 figures, Accepted for publication in Solar Physic

Mini-magnetospheres above the lunar surface and the formation of lunar swirls

In this paper we present in-situ satellite data, theory and laboratory validation that show how small scale collisionless shocks and mini-magnetospheres can form on the electron inertial scale length. The resulting retardation and deflection of the solar wind ions could be responsible for the unusual "lunar swirl" patterns seen on the surface of the Moon.Comment: 5 pages, 5 figure

Soft systems methodology: a context within a 50-year retrospective of OR/MS

Soft systems methodology (SSM) has been used in the practice of operations research and management science OR/MS) since the early 1970s. In the 1990s, it emerged as a viable academic discipline. Unfortunately, its proponents consider SSM and traditional systems thinking to be mutually exclusive. Despite the differences claimed by SSM proponents between the two, they have been complementary. An extensive sampling of the OR/MS literature over its entire lifetime demonstrates the richness with which the non-SSM literature has been addressing the very same issues as does SSM

The immunopathology of ANCA-associated vasculitis.

The small-vessel vasculitides are a group of disorders characterised by variable patterns of small blood vessel inflammation producing a markedly heterogeneous clinical phenotype. While any vessel in any organ may be involved, distinct but often overlapping sets of clinical features have allowed the description of three subtypes associated with the presence of circulating anti-neutrophil cytoplasmic antibodies (ANCA), namely granulomatosis with polyangiitis (GPA, formerly known as Wegener's Granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (eGPA, formerly known as Churg-Strauss syndrome). Together, these conditions are called the ANCA-associated vasculitidies (AAV). Both formal nomenclature and classification criteria for the syndromes have changed repeatedly since their description over 100 years ago and may conceivably do so again following recent reports showing distinct genetic associations of patients with detectable ANCA of distinct specificities. ANCA are not only useful in classifying the syndromes but substantial evidence implicates them in driving disease pathogenesis although the mechanism by which they develop and tolerance is broken remains controversial. Advances in our understanding of the pathogenesis of the syndromes have been accompanied by some progress in treatment, although much remains to be done to improve the chronic morbidity associated with the immunosuppression required for disease control

ANCA-associated vasculitis.

The anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are a group of disorders involving severe, systemic, small-vessel vasculitis and are characterized by the development of autoantibodies to the neutrophil proteins leukocyte proteinase 3 (PR3-ANCA) or myeloperoxidase (MPO-ANCA). The three AAV subgroups, namely granulomatosis with polyangiitis (GPA), microscopic polyangiitis and eosinophilic GPA (EGPA), are defined according to clinical features. However, genetic and other clinical findings suggest that these clinical syndromes may be better classified as PR3-positive AAV (PR3-AAV), MPO-positive AAV (MPO-AAV) and, for EGPA, by the presence or absence of ANCA (ANCA+ or ANCA-, respectively). Although any tissue can be involved in AAV, the upper and lower respiratory tract and kidneys are most commonly and severely affected. AAVs have a complex and unique pathogenesis, with evidence for a loss of tolerance to neutrophil proteins, which leads to ANCA-mediated neutrophil activation, recruitment and injury, with effector T cells also involved. Without therapy, prognosis is poor but treatments, typically immunosuppressants, have improved survival, albeit with considerable morbidity from glucocorticoids and other immunosuppressive medications. Current challenges include improving the measures of disease activity and risk of relapse, uncertainty about optimal therapy duration and a need for targeted therapies with fewer adverse effects. Meeting these challenges requires a more detailed knowledge of the fundamental biology of AAV as well as cooperative international research and clinical trials with meaningful input from patients